HER2 and surgery: more questions to answer

Lancet. 2003 Aug 16;362(9383):502-3. doi: 10.1016/S0140-6736(03)14147-5.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / therapeutic use
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / genetics
  • Breast Neoplasms / surgery
  • Female
  • Genes, erbB-2 / drug effects
  • Genes, erbB-2 / genetics
  • Genes, erbB-2 / physiology
  • Humans
  • Receptor, ErbB-2* / drug effects
  • Receptor, ErbB-2* / genetics
  • Receptor, ErbB-2* / metabolism
  • Surgical Procedures, Operative*
  • Trastuzumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Receptor, ErbB-2
  • Trastuzumab